Synapse Webinar: Novel Approaches in Antimicrobial Resistance
Antimicrobial resistance (AMR) poses a serious threat to global public health. According to a report published by World Health Organization (WHO) in 2019, if no action is taken, drug-resistant diseases could cause more than 10 million deaths every year by 2050 – which is more than cancer.
Emerging new resistance mechanisms in microorganisms pose a serious threat to global public health. With the COVID-19 pandemic, we have all just seen how vulnerable we can be when a disease spreads globally, and the situation is very serious with antimicrobial resistance because only a few new antimicrobial drugs reach the market. The result is that some of our most powerful drugs are becoming useless and we can no longer treat common infectious diseases. Although AMR is becoming a recognized global issue, WHO is still calling for more focus on R&D, awareness and education, and alternative investments in the area so we can avoid this future crisis.
Date: May 27th 2020
Time: 17:00 – 18:00
Lisa Bugge Toft, Project Manager (ICARS, International Centre for Antimicrobial resistance solutions)
Albert Pallejà Caro, PhD (Clinical Microbiomics)
Eric van der Helm, PhD (SNIPR Biome)
Please contact firstname.lastname@example.org for any questions regarding the event.